Literature DB >> 11495226

Discovery of a novel serine protease inhibitor utilizing a structure-based and experimental selection of fragments technique.

S Makino1, T Kayahara, K Tashiro, M Takahashi, T Tsuji, M Shoji.   

Abstract

We report a set of strategies to develop novel ligands (Structure Based and Experimental Selection of Fragments: SbE-SF). First, a docking simulation utilizing DOCK3.5 is performed in order to screen the fragment database, which was generated with the in-house program FRAGMENT++ specifically for docking simulation purposes. Although the affinity of these small molecules (fragments) is expected to be low, the affinity of fragments selected by computation is assayed by experiment to determine which ones can be potent inhibitors. After determining such key fragments. additional fragments are attached to the key ones in order to increase the binding affinity,taking into account the binding modes predicted by computation. This method has been applied to a thrombin inhibitor study, resulting in the discovery of a novel inhibitor exhibiting pIC50 = 7.9.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11495226     DOI: 10.1023/a:1011196407163

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  15 in total

1.  DREAM++: flexible docking program for virtual combinatorial libraries.

Authors:  S Makino; T J Ewing; I D Kuntz
Journal:  J Comput Aided Mol Des       Date:  1999-09       Impact factor: 3.686

2.  The SHAPES strategy: an NMR-based approach for lead generation in drug discovery.

Authors:  J Fejzo; C A Lepre; J W Peng; G W Bemis; M A Murcko; J M Moore
Journal:  Chem Biol       Date:  1999-10

3.  Computer design of bioactive molecules: a method for receptor-based de novo ligand design.

Authors:  J B Moon; W J Howe
Journal:  Proteins       Date:  1991

4.  Crystallographic analysis at 3.0-A resolution of the binding to human thrombin of four active site-directed inhibitors.

Authors:  D W Banner; P Hadváry
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

5.  Towards the automatic design of synthetically accessible protein ligands: peptides, amides and peptidomimetics.

Authors:  H J Böhm
Journal:  J Comput Aided Mol Des       Date:  1996-08       Impact factor: 3.686

6.  Hammerhead: fast, fully automated docking of flexible ligands to protein binding sites.

Authors:  W Welch; J Ruppert; A N Jain
Journal:  Chem Biol       Date:  1996-06

7.  BUILDER v.2: improving the chemistry of a de novo design strategy.

Authors:  D C Roe; I D Kuntz
Journal:  J Comput Aided Mol Des       Date:  1995-06       Impact factor: 3.686

8.  Confirmation of usefulness of a structure construction program based on three-dimensional receptor structure for rational lead generation.

Authors:  Y Nishibata; A Itai
Journal:  J Med Chem       Date:  1993-10-01       Impact factor: 7.446

9.  DX-9065a, a new synthetic, potent anticoagulant and selective inhibitor for factor Xa.

Authors:  T Hara; A Yokoyama; H Ishihara; Y Yokoyama; T Nagahara; M Iwamoto
Journal:  Thromb Haemost       Date:  1994-03       Impact factor: 5.249

Review 10.  Interactions of thrombin with benzamidine-based inhibitors.

Authors:  J Stürzebecher; H Vieweg; P Wikström; D Turk; W Bode
Journal:  Biol Chem Hoppe Seyler       Date:  1992-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.